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Edited by Barry HalliwellAbstract Gastric acid production is important in intestinal iron
absorption. The peptide hormone gastrin exists in both amidated
and non-amidated forms, which stimulate and potentiate gastric
acid secretion, respectively. Since non-amidated gastrins require
ferric ions for biological activity in vitro, this study investigated
the connection between iron status and gastrin by measurement
of circulating gastrin concentrations in mice and humans with
hemochromatosis. Gastrin concentrations are increased in the
plasma and gastric mucosa ofHfe/ mice, and in the sera of hu-
mans with HFE-related hemochromatosis. The discovery of a
relationship between iron status and circulating gastrin concen-
trations opens a new perspective on the mechanisms of iron
homeostasis.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The importance of gastric acid production in dietary iron
absorption was ﬁrst recognised nearly 50 years ago, when
Baird and co-workers reported that iron-deﬁciency anemia is
a long-term consequence of partial gastrectomy [1]. Although
the peptide hormone gastrin has long been recognised as a
major regulator of gastric acid secretion [2], the possibility of
a connection between iron status and circulating gastrins has
not been investigated previously.
All forms of gastrin, including amidated gastrin17 (Gamide)
and glycine-extended gastrin17 (Ggly), are derived from an 80
amino acid precursor, progastrin [2]. C-terminal amidation is
essential for the biological activities of Gamide as a stimulant
of gastric acid secretion and a growth factor for the gastric mu-
cosa [2]. However, non-amidated forms such as Ggly have
been shown to potentiate gastric acid secretion [3], and to stim-
ulate proliferation in the colorectal mucosa [4–6]. Amidated
gastrins act via the cholecystokinin2 (CCK2 receptor), but
the receptor that mediates the eﬀects of non-amidated gastrins
has not been deﬁned [7]. We have previously reported thatAbbreviations: CCK2 receptor, cholecystokinin2 receptor; Gamide,
amidated gastrin17; Ggly, glycine-extended gastrin17
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via glutamates 7–9 [8,9]. Ferric ion binding is essential for
Ggly’s biological activity since replacement of glutamate 7
by alanine [9], or addition of iron chelators [9] or bismuth ions
[10], renders Ggly inactive. In contrast, although Gamide also
binds two ferric ions [8], their removal has no eﬀect on biolog-
ical activity [11].
Although our in vitro observation that non-amidated gas-
trins require ferric ions for biological activity [9] suggests that
a connection may exist between iron status and gastrins, this
proposal has not been tested in vivo. We therefore measured
concentrations of Gamide and Ggly in the plasma and in gas-
tric mucosal extracts of mice with hemochromatosis as a result
of deletion of the Hfe gene [12]. Serum Gamide and Ggly con-
centrations were also investigated in humans with HFE-related
hemochromatosis.2. Materials and methods
2.1. Patients
Patients with hemochromatosis have been described previously [13].
Blood sample collection was approved by the Queensland Institute of
Medical Research Human Ethics Committee and written informed
consent was obtained from all individuals.2.2. Mouse strains
C57BL/6J Hfe/ mice [12] were obtained from Dr. Robert Fleming
(Department of Pediatrics, St. Louis University School of Medicine,
St. Louis, MO). Equal numbers of male and female mice (9–11 weeks
of age) were fed a commercial pelleted diet, given water ad libitum, and
fasted overnight before being anesthetised with ethrane prior to eutha-
nasia and collection of plasma and tissue. All experiments described in
this study were approved by the Austin Health or Queensland Institute
of Medical Research Animal Ethics Committees.2.3. Peptide extraction and radioimmunoassay
Peptides were extracted by boiling whole murine stomachs in 3 vol
of water followed by mechanical homogenisation (Polytron, Brink-
man Instruments, Lucerne, Switzerland). After centrifugation
(10000 rpm, 15 min, 4 C) supernatants were collected for radioimmu-
noassay. Murine plasma was collected from centrifuged blood ob-
tained by cardiac puncture. For both human and murine samples
amidated gastrin was measured as described previously by radioimmu-
noassay against an amidated gastrin17 standard curve with 125I-ami-
dated gastrin17 as label with antiserum 1296, which recognises the
amidated C-terminal pentapeptide, detects all fragments greater than
the pentapeptide and does not cross react with cholecystokinin or
Ggly [14]. Ggly was assayed as described previously by radioimmuno-
assay against a gastrin17gly standard curve with 125I-gastrin17gly as
label with antiserum 7270, which does not cross-react with Gamide
[14].blished by Elsevier B.V. All rights reserved.
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The morphology of the gastric mucosa was assessed after staining
with hematoxylin/eosin [15]. Gastric parietal cells were detected by
immunoﬂuorescent staining for the b-subunit of the gastric H+/K+-
ATPase with the monoclonal antibody 2B6 as previously described
[16].
2.5. Gastric pH determination
The pH of the gastric contents was determined by the method of
Koh and co-workers [17], except that 1 ml of saline was used for ﬂush-
ing.
2.6. Statistics
Data are means ± S.E. Statistical signiﬁcance relative to the control
(*P < 0.05; **P < 0.01; #P < 0.001) was assessed by one-way ANOVA,
followed by Student’s t-test with Bonferroni correction.3. Results and discussion
We have previously reported that gastrins bind two ferric
ions with high aﬃnity [8], and that ferric ion binding is essen-
tial for the biological activity of Ggly [9]. In order to determine
whether there is a hitherto unsuspected connection between
circulating gastrins and iron status, Gamide and Ggly concen-
trations were assayed in plasma and gastric mucosal extractsFig. 1. Circulating gastrin is increased in hemochromatosis. The concentratio
mucosal extracts (C, D) of mice, and in the sera of patients with hemochro
C57BL/6J (n = 10) or Hfe/ (n = 20) mice were fasted overnight before colle
respectively) and the mean age of the control and HFE groups, and the num
means ± S.E. Statistical signiﬁcance relative to the control (*P < 0.05; **P
Student’s t-test with Bonferroni correction.from Hfe/ mice, which develop the iron loading disease
hemochromatosis [12]. Both Gamide and Ggly concentrations
were signiﬁcantly higher in the plasma of Hfe/ mice com-
pared with wild-type controls (Fig. 1A,B). The concentration
of Ggly was also fourfold higher in the gastric mucosal extracts
from Hfe/ mice (Fig. 1D). The failure to detect a signiﬁcant
increase in Gamide concentration in the gastric mucosal ex-
tracts from Hfe/ mice (Fig. 1C) may be a consequence of
the far higher baseline concentration of Gamide relative to
Ggly, since the same absolute increase in gastrin concentration
will result in a much lower percentage increase in Gamide con-
centration. The changes in gastrin concentration are not an
artefact caused by changes in the plasma iron concentration,
since the measurement of Gamide concentration by radioim-
munoassay is not aﬀected by addition of ferric ions
(112 ± 5% of initial concentration), or by removal of any
adventitious metal ions by chelation with EDTA (110 ± 3%).
The observed changes appear to be due to diﬀerences in trans-
lation of gastrin mRNA or in processing of progastrin since no
signiﬁcant diﬀerences in the concentration of gastrin mRNA
between mouse strains were detected by real time PCR (data
not shown).
In order to investigate whether or not the connection be-
tween circulating gastrin concentrations and iron status ob-ns of Gamide (A, C, E) and Ggly (B, D, F) in plasma (A, B) and gastric
matosis (E, F), were measured by radioimmunoassay [14]. Wild-type
ction of plasma and tissue samples. The total numbers (n = 41 and 40,
bers of male and female patients, were approximately equal. Data are
< 0.01; #P < 0.001) was assessed by one-way ANOVA, followed by
Fig. 2. The observed changes in gastrin concentrations in mice with
disordered iron metabolism are not due to structural changes in the
gastric mucosa. The morphology (assessed by staining with hematox-
ylin/eosin (A, B)), and the numbers of gastric parietal cells (assessed by
staining for the gastric H+/K+-ATPase (C, D)), were the same in wild-
type (A, C) and Hfe/ (B, D) mice. The scale bar in A represents
50 lm; panels A–D are at the same magniﬁcation. Similarly, the
changes in gastrin concentration were not due to an increased pH, as
the pH of the luminal contents (E) was lower in the Hfe/ mice than
in controls.
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tions were measured in sera from patients with HFE-related
hemochromatosis. In parallel with the murine studies, circulat-
ing Gamide and Ggly (Fig. 1E, F) concentrations were signif-
icantly greater in hemochromatotic patients compared with a
group of normal controls with a similar mean age and sex ra-
tio. Since infection with Helicobacter pylori (H. pylori) can in-
crease circulating gastrin concentrations [2], the comparison
was repeated in H. pylori-negative patients (n = 35). The fact
that the diﬀerence was of similar magnitude and still signiﬁcant
(P < 0.001, data not shown) indicated that the observed in-
crease in circulating gastrin concentrations in hemochroma-
totic patients was not due to infection with H. pylori.
Several alternative explanations were considered for the ob-
served increases in circulating gastrin concentrations in mice
and humans with HFE-related hemochromatosis. In the case
of the murine samples the possibilities that the increases might
have been due to structural changes or to diﬀerences in bacte-
rial colonisation of the stomach [18] were eliminated by the
failure to detect signiﬁcant morphological diﬀerences between
strains (Fig. 2A,B). The possibility was also considered that
the changes in gastrin concentrations might have been due to
an increased luminal pH, since reduced acid secretion leads
to a compensatory increase in circulating gastrin [2]. This
explanation could be eliminated as there was no diﬀerence in
the numbers of parietal cells (Fig. 2C,D), and as the pH of
the luminal contents was lower in the iron-overloaded mice
than in controls (Fig. 2E). The fact that animals were fasted
overnight before collection of plasma and tissue also eliminates
feeding diﬀerences as a cause of the observed changes in gas-
trin concentrations. Since the HFE protein is expressed in
the gastric antrum [19] the observed increases in circulating
gastrin concentrations may either be a direct eﬀect of the
HFE mutation, or alternatively may be the result of the altered
iron homeostasis consequent on HFE mutation.
How do our data ﬁt with current models of iron homeosta-
sis? The regulatory peptide hepcidin is known to play a central
role in the regulation of iron transport [20,21]. A reduction in
the circulating concentration of hepcidin, such as is observed
in HFE-related hemachromatosis [22], results in reduced inter-
nalisation of the iron transporter ferroportin, and hence to in-
creased iron export from intestinal enterocytes [23]. Our data
suggest that a second unexpected correlate of reduced circulat-
ing hepcidin may be an increase in antral and/or circulating
gastrins. The increase in circulating gastrins would stimulate
gastric acid secretion, which would in turn lower luminal pH
(Fig. 2E), promote the release of ferric ions from food in the
stomach, and hence increase the availability of iron for intesti-
nal uptake. While other models are also feasible and require
assessment, in this model hepcidin controls cellular iron export
and gastrins, under the control of hepcidin, modulate the
availability of dietary iron.
The model is consistent with the earlier observation that iron-
deﬁciency anemia is a long-term consequence of partial gastrec-
tomy [1]. The reduction in iron uptake could either be a direct
consequence of the removal of the source of gastrins, or indi-
rectly by reduction in the amount of gastric acid released in re-
sponse to gastrins [1]. The observations that there was no
reduction in ferrous ion absorption in humans after removal
of the source of gastrin by antrectomy, but that absorption
was lower in antrectomised patients with acid secretion reduced
by vagotomy, suggested that gastric acid was the critical factor[24]. The importance of gastric acid was further demonstrated
by the observation that administration of the histamine H2
receptor antagonist cimetidine to human volunteers resulted
in reduced acid secretion and a 65% decrease in iron absorption
[25]. However later reports indicated that long-term treatment
of humans with the proton pump inhibitor omeprazole did not
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zole only decreased iron absorption if the animals were on an
iron-deﬁcient diet [27]. Interestingly, iron deﬁciency in rats
has itself been reported to reduce acid secretion [28]. Further
studies using other means to modify iron status are clearly re-
quired to detail the relationships between iron status and gas-
trin. Such studies might include modiﬁcation of dietary iron
intake and chemical induction of anemia.
In conclusion, the experimental data presented in this paper
provide convincing evidence for a previously unsuspected rela-
tionship between circulating gastrins and iron status. When
taken together with our in vitro observations that non-ami-
dated gastrins require ferric ions for biological activity [8,9],
there is now strong evidence for relationships between gastrin
expression, gastrin bioactivity and iron homeostasis, and tan-
talising glimpses of connections between gastrin and iron in
colorectal cancer. For example the increased risk of colorectal
cancer in patients with HFE mutations [29] may be related to
their increased concentrations of circulating gastrins
(Fig. 1E,F), since circulating Gamide concentrations above
normal are also associated with an increased risk of colorectal
cancer [30]. Although the detailed implications of our ﬁndings
remain to be explored, the connection between hemochromato-
sis and circulating gastrins opens new perspectives on the mech-
anisms of iron homeostasis and colorectal cancer development.
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